Study: NCT04240626

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neurontin
Description: 600 mg on-call prior to surgery, post surgery 100 mg liquid q 8-12 hours post surgery with Tylenol every 6 hours

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dilaudid Injectable Product
Description: .5-1 mg IV Q3 hours and IV Tylenol 1000mg every 6 hours post surgery transitioning to oral pain control medications (Hycet 7.5/325mg/5 ml, 5-10 ml every 4 hours

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dilaudid Injectable Product
Description: .5-1 mg IV Q3 hours and IV Tylenol 1000mg every 6 hours post surgery transitioning to oral pain control medications (Hycet 7.5/325mg/5 ml, 5-10 ml every 4 hours

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Marcaine Injectable Product
Description: 0.25% local injectable anesthetic agent infiltrated at all laparoscopic incision sites for both groups.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Marcaine Injectable Product
Description: 0.25% local injectable anesthetic agent infiltrated at all laparoscopic incision sites for both groups.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxycodone Hydrochloride
Description: 1 mg/ml oral solution, dosage 5-10mg q4h prn for pain control

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxycodone Hydrochloride
Description: 1 mg/ml oral solution, dosage 5-10mg q4h prn for pain control

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hycet 7.5Mg-325Mg/15Ml Solution
Description: Dosage: 10-15ml q4h prn for pain control

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hycet 7.5Mg-325Mg/15Ml Solution
Description: Dosage: 10-15ml q4h prn for pain control

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zofran Injection
Description: 4 mg IV for nausea control while inpatient, prn

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zofran Injection
Description: 4 mg IV for nausea control while inpatient, prn

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Scopolamine patch
Description: Topical application patch for nausea control, used with/without Ativan.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Scopolamine patch
Description: Topical application patch for nausea control, used with/without Ativan.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ativan
Description: 0.5mg IV as needed in conjunction with/without Scopolamine and Zofran for Nausea control

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ativan
Description: 0.5mg IV as needed in conjunction with/without Scopolamine and Zofran for Nausea control

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flexeril Oral Product
Description: 5 mg orally q8h prn for muscle spasms.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Flexeril Oral Product
Description: 5 mg orally q8h prn for muscle spasms.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tylenol Suspension
Description: 1000 mg q6h PRN for pain control.